When apoptosis is disabled, mice develop MDS-like disease, characterized by increased Ripk1 expression and MLKL activation, features that are also observed in a subset of human MDS samples. HSC, hematopoietic stem cell; IFN, interferon; IL-1β, interleukin-1β.